Vivo Bio Tech Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Net profit of Vivo Bio Tech declined 85.82% to Rs 0.19 crore in the quarter ended June 2026 as against Rs 1.34 crore during the previous quarter ended June 2025. Sales rose 14.15% to Rs 14.28 crore in the quarter ended June 2026 as against Rs 12.51 crore during the previous quarter ended June 2025.

Powered by Capital Market - Live News

Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 13 July 2026.

Vivo Bio Tech has postponed the meeting of the Board of Directors which was scheduled to be held on 29 May 2026. The meeting will now be held on 30 May 2026.

Net loss of Vivo Bio Tech reported to Rs 5.16 crore in the quarter ended March 2026 as against net profit of Rs 1.06 crore during the previous quarter ended March 2025. Sales rose 15.54% to Rs 14.20 crore in the quarter ended March 2026 as against Rs 12.29 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.71 crore in the year ended March 2026 as against net profit of Rs 7.28 crore during the previous year ended March 2025. Sales rose 14.27% to Rs 53.33 crore in the year ended March 2026 as against Rs 46.67 crore during the previous year ended March 2025.

Powered by Capital Market - Live News